Navigation Links
Medical societies unite on patient-centered measures for nonsurgical stroke interventions
Date:1/29/2013

FAIRFAX, Va.The first outcome-based guidelines for interventional treatment of acute ischemic strokeproviding recommendations for rapid treatmentwill benefit individuals suffering from brain attacks, often caused by artery-blocking blood clots. Representatives from the Society of Interventional Radiology and seven other medical societies created a multispecialty and international consensus on the metrics and benchmarks for processes of care and technical and clinical outcomes for stroke patients.

In February, the guidelines will be published first in SIR's Journal of Vascular and Interventional Radiology and subsequently by each society either in its respective journal or on its website.

"These groundbreaking guidelines are the product of two years of collaboration among multidisciplinary teams from eight societies," said Marshall E. Hicks, M.D., FSIR, president of the Society of Interventional Radiology, the national society of nearly 5,000 doctors, scientists and allied health professionals dedicated to improving health care through minimally invasive treatments. "With real progress being made in research and treatment of stroke over the last decade, this distinguished group of international authorsfrom societies whose members perform minimally invasive stroke treatmentsfelt that the time was right for a consensus on how to effectively treat and manage stroke patients," said Hicks, the head of the division of diagnostic imaging at the University of Texas MD Anderson Cancer Center in Houston.

"The one constant in stroke treatment is time," noted David Sacks, M.D., FSIR, an interventional radiologist at Reading Hospital and Medical Center in West Reading, Pa., and the study's lead author. "Seconds count from time of admission to treatment. Meeting the outcomes described in these guidelines will ultimately benefit patients by requiring strict adherence to a rapid treatment schedule," he added. Stroke is the fourth leading cause of adult death and disability in the United States and the third leading cause of death in Canada, Europe and Japan.

The guidelines recommend submission of outcomes to a national registry that will allow research and also comparisons between facilities. Sacks noted that the benchmarks in the paper are intended to be used in a quality assurance program to assess and improve processes and outcomes in acute stroke revascularization, which is the opening of a blocked artery to the brain. He said that the guidelines may also be helpful to facilities that are interested in applying for accreditation as a comprehensive stroke center. "As the field of stroke revascularization evolves, the guidelines will be revised as needed," he added.

In 2003, the Journal of Vascular and Interventional Radiology published a joint society document to guide the design and reporting of stroke research; the new guidelines address clinical care. The co-authors completed a review of the relevant literature from 1986 through February 2012 as the basis for creating performance metrics and thresholds. "All society representatives vigorously discussed each issue based on the literature review and personal experience," said Sacks.


'/>"/>

Contact: Ellen Acconcia
eacconcia@sirweb.org
703-460-5582
Society of Interventional Radiology
Source:Eurekalert

Related biology news :

1. A call to prevent unsafe high-risk medical devices from reaching the marketplace
2. UTSA engineer Hai-Chao Han named Fellow of Medical and Biological Engineering Institute
3. Improving the development of new cancer models using an advanced biomedical imaging method
4. Lyncean Technologies Inc. sells Compact Light Source to Munich biomedical-imaging research center
5. Wake Forest Baptist Medical Center Launches Wake Forest Innovations
6. UMass Medical School faculty elected to the American Association for the Advancement of Science
7. Surgical Theater, LLC sells first Surgical Rehearsal Platform to UH Case Medical Center
8. Mainz University Medical Center agrees partnership with Yale University
9. Medbox, Inc. Releases Demo Video and Collateral Media Concerning How Their Systems Will Be Used in Massachusetts Medical Marijuana Dispensaries
10. Stryker Chooses Wineman Technology for Medical Device Test Equipment and Software
11. FASEB urges biomedical research community to speak out against sequestration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology: